sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Covid-19 Impact on Global Oral Vaccine Market Research Report 2020

Covid-19 Impact on Global Oral Vaccine Market Research Report 2020

Home / Categories / Healthcare
Covid-19 Impact on Global Oral Vaccine Market Research Report 2020
Covid-19 Impact on Global Oral...
Report Code
RO1/129/28742

Publish Date
07/Nov/2020

Pages
134
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oral Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global Oral Vaccine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Rotavirus Vaccine
1.4.3 Cholera Vaccine
1.4.4 Oral Polio Vaccine
1.4.5 Others
1.5 Market by Application
1.5.1 Global Oral Vaccine Market Share by Application: 2021-2026
1.5.2 Public
1.5.3 Private
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Oral Vaccine Market
1.8.1 Global Oral Vaccine Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Oral Vaccine Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Oral Vaccine Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Oral Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Oral Vaccine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Oral Vaccine Sales Volume Market Share by Region (2015-2020)
3.2 Global Oral Vaccine Sales Revenue Market Share by Region (2015-2020)
3.3 North America Oral Vaccine Sales Volume
3.3.1 North America Oral Vaccine Sales Volume Growth Rate (2015-2020)
3.3.2 North America Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Oral Vaccine Sales Volume
3.4.1 East Asia Oral Vaccine Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Oral Vaccine Sales Volume (2015-2020)
3.5.1 Europe Oral Vaccine Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Oral Vaccine Sales Volume (2015-2020)
3.6.1 South Asia Oral Vaccine Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Oral Vaccine Sales Volume (2015-2020)
3.7.1 Southeast Asia Oral Vaccine Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Oral Vaccine Sales Volume (2015-2020)
3.8.1 Middle East Oral Vaccine Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Oral Vaccine Sales Volume (2015-2020)
3.9.1 Africa Oral Vaccine Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Oral Vaccine Sales Volume (2015-2020)
3.10.1 Oceania Oral Vaccine Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Oral Vaccine Sales Volume (2015-2020)
3.11.1 South America Oral Vaccine Sales Volume Growth Rate (2015-2020)
3.11.2 South America Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Oral Vaccine Sales Volume (2015-2020)
3.12.1 Rest of the World Oral Vaccine Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Oral Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Oral Vaccine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Oral Vaccine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Oral Vaccine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Oral Vaccine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Oral Vaccine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Oral Vaccine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Oral Vaccine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Oral Vaccine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Oral Vaccine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Oral Vaccine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Oral Vaccine Sales Volume Market Share by Type (2015-2020)
14.2 Global Oral Vaccine Sales Revenue Market Share by Type (2015-2020)
14.3 Global Oral Vaccine Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Oral Vaccine Consumption Volume by Application (2015-2020)
15.2 Global Oral Vaccine Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Oral Vaccine Business
16.1 Merck
16.1.1 Merck Company Profile
16.1.2 Merck Oral Vaccine Product Specification
16.1.3 Merck Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Bibcol
16.2.1 Bibcol Company Profile
16.2.2 Bibcol Oral Vaccine Product Specification
16.2.3 Bibcol Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Lanzhou Institute
16.3.1 Lanzhou Institute Company Profile
16.3.2 Lanzhou Institute Oral Vaccine Product Specification
16.3.3 Lanzhou Institute Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 GSK
16.4.1 GSK Company Profile
16.4.2 GSK Oral Vaccine Product Specification
16.4.3 GSK Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Shanghai United Cell
16.5.1 Shanghai United Cell Company Profile
16.5.2 Shanghai United Cell Oral Vaccine Product Specification
16.5.3 Shanghai United Cell Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Sanofi
16.6.1 Sanofi Company Profile
16.6.2 Sanofi Oral Vaccine Product Specification
16.6.3 Sanofi Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Vabiotech
16.7.1 Vabiotech Company Profile
16.7.2 Vabiotech Oral Vaccine Product Specification
16.7.3 Vabiotech Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Valneva
16.8.1 Valneva Company Profile
16.8.2 Valneva Oral Vaccine Product Specification
16.8.3 Valneva Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Serum Institute
16.9.1 Serum Institute Company Profile
16.9.2 Serum Institute Oral Vaccine Product Specification
16.9.3 Serum Institute Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 PaxVax
16.10.1 PaxVax Company Profile
16.10.2 PaxVax Oral Vaccine Product Specification
16.10.3 PaxVax Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Halfkin Bio-Pharmaceuticals
16.11.1 Halfkin Bio-Pharmaceuticals Company Profile
16.11.2 Halfkin Bio-Pharmaceuticals Oral Vaccine Product Specification
16.11.3 Halfkin Bio-Pharmaceuticals Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Tiantan Biological
16.12.1 Tiantan Biological Company Profile
16.12.2 Tiantan Biological Oral Vaccine Product Specification
16.12.3 Tiantan Biological Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Bio-Med
16.13.1 Bio-Med Company Profile
16.13.2 Bio-Med Oral Vaccine Product Specification
16.13.3 Bio-Med Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 EuBiologics
16.14.1 EuBiologics Company Profile
16.14.2 EuBiologics Oral Vaccine Product Specification
16.14.3 EuBiologics Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 Panacea Biotec Ltd
16.15.1 Panacea Biotec Ltd Company Profile
16.15.2 Panacea Biotec Ltd Oral Vaccine Product Specification
16.15.3 Panacea Biotec Ltd Oral Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Oral Vaccine Manufacturing Cost Analysis
17.1 Oral Vaccine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Oral Vaccine
17.4 Oral Vaccine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Oral Vaccine Distributors List
18.3 Oral Vaccine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Oral Vaccine (2021-2026)
20.2 Global Forecasted Revenue of Oral Vaccine (2021-2026)
20.3 Global Forecasted Price of Oral Vaccine (2015-2026)
20.4 Global Forecasted Production of Oral Vaccine by Region (2021-2026)
20.4.1 North America Oral Vaccine Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Oral Vaccine Production, Revenue Forecast (2021-2026)
20.4.3 Europe Oral Vaccine Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Oral Vaccine Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Oral Vaccine Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Oral Vaccine Production, Revenue Forecast (2021-2026)
20.4.7 Africa Oral Vaccine Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Oral Vaccine Production, Revenue Forecast (2021-2026)
20.4.9 South America Oral Vaccine Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Oral Vaccine Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Oral Vaccine by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Oral Vaccine by Country
21.2 East Asia Market Forecasted Consumption of Oral Vaccine by Country
21.3 Europe Market Forecasted Consumption of Oral Vaccine by Countriy
21.4 South Asia Forecasted Consumption of Oral Vaccine by Country
21.5 Southeast Asia Forecasted Consumption of Oral Vaccine by Country
21.6 Middle East Forecasted Consumption of Oral Vaccine by Country
21.7 Africa Forecasted Consumption of Oral Vaccine by Country
21.8 Oceania Forecasted Consumption of Oral Vaccine by Country
21.9 South America Forecasted Consumption of Oral Vaccine by Country
21.10 Rest of the world Forecasted Consumption of Oral Vaccine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com